ArticlePloS one2019

Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapy.

Kevin Shee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.